Prenumeration
Cereno Scientific’s report for the first quarter highlights continued progress. During the period, advancements were made in both the CS1 and CS014 programs, alongside key milestones in regulatory discussions and the company’s patent portfolio.
Read more at biostock.se:
https://biostock.se/en/2025/05/cereno-scientific-advances-on-multiple-fronts-in-q1/
Follow BioStock
Stay updated with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow us on social media: LinkedIn and FaceBook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.